Temple University cherry "T" logo

Lewis Katz School of Medicine

Search Keywords

Recent Publications

2023-2024 - Katz Faculty publications

  1. Arjona SP, Allen CNS, Santerre M, Gross S, Soboloff J, Booze R, Sawaya BE. Disruption of Mitochondrial-associated ER membranes by HIV-1 tat protein contributes to premature brain aging. CNS Neurosci Ther. 2023;29(1):365-77. Epub 20221123. doi: 10.1111/cns.14011. PubMed PMID: 36419337; PMCID: PMC9804058.
  2. Bagnyukova T, Egleston BL, Pavlov VA, Serebriiskii IG, Golemis EA, Borghaei H. Synergy of EGFR and AURKA Inhibitors in KRAS-mutated Non-small Cell Lung Cancers. Cancer Res Commun. 2024;4(5):1227-39. doi: 10.1158/2767-9764.Crc-23-0482. PubMed PMID: 38639476; PMCID: PMC11078142.
  3. Barszczewska-Pietraszek G, Czarny P, Drzewiecka M, Błaszczyk M, Radek M, Synowiec E, Wigner-Jeziorska P, Sitarek P, Szemraj J, Skorski T, Śliwiński T. Polθ Inhibitor (ART558) Demonstrates a Synthetic Lethal Effect with PARP and RAD52 Inhibitors in Glioblastoma Cells. Int J Mol Sci. 2024;25(17). Epub 20240823. doi: 10.3390/ijms25179134. PubMed PMID: 39273083; PMCID: PMC11395082.
  4. Calbert ML, Chandramouly G, Adams CM, Saez-Ayala M, Kent T, Tyagi M, Ayyadevara V, Wang Y, Krais JJ, Gordon J, Atkins J, Toma MM, Betzi S, Boghossian AS, Rees MG, Ronan MM, Roth JA, Goldman AR, Gorman N, Mitra R, Childers WE, Graña X, Skorski T, Johnson N, Hurtz C, Morelli X, Eischen CM, Pomerantz RT. 4'-Ethynyl-2'-Deoxycytidine (EdC) Preferentially Targets Lymphoma and Leukemia Subtypes by Inducing Replicative Stress. Mol Cancer Ther. 2024;23(5):683-99. doi: 10.1158/1535-7163.Mct-23-0487. PubMed PMID: 38064712; PMCID: PMC11286238.
  5. Chang WL, Ghosh J, Cooper HS, Vanderveer L, Schultz B, Zhou Y, Harvey KN, Kaunga E, Devarajan K, Li Y, Jelinek J, Fragoso MF, Sapienza C, Clapper ML. Folic Acid Supplementation Promotes Hypomethylation in Both the Inflamed Colonic Mucosa and Colitis-Associated Dysplasia. Cancers (Basel). 2023;15(11). Epub 20230527. doi: 10.3390/cancers15112949. PubMed PMID: 37296911; PMCID: PMC10252136.
  6. Chioccioli M, Liu S, Magruder S, Tata A, Borriello L, McDonough JE, Konkimalla A, Kim SH, Nouws J, Gonzalez DG, Traub B, Ye X, Yang T, Entenberg DR, Krishnaswamy S, Hendry CE, Kaminski N, Tata PR, Sauler M. Stem cell migration drives lung repair in living mice. Dev Cell. 2024;59(7):830-40.e4. Epub 20240219. doi: 10.1016/j.devcel.2024.02.003. PubMed PMID: 38377991; PMCID: PMC11003834.
  7. Clevenger MH, Karami AL, Carlson DA, Kahrilas PJ, Gonsalves N, Pandolfino JE, Winter DR, Whelan KA, Tétreault MP. Suprabasal cells retain progenitor cell identity programs in eosinophilic esophagitis-driven basal cell hyperplasia. JCI Insight. 2023;8(19). Epub 20231009. doi: 10.1172/jci.insight.171765. PubMed PMID: 37672481; PMCID: PMC10619442.
  8. Demidova EV, Serebriiskii IG, Vlasenkova R, Kelow S, Andrake MD, Hartman TR, Kent T, Virtucio J, Rosen GL, Pomerantz RT, Dunbrack RL, Jr., Golemis EA, Hall MJ, Chen DYT, Daly MB, Arora S. Candidate variants in DNA replication and repair genes in early-onset renal cell carcinoma patients referred for germline testing. BMC Genomics. 2023;24(1):212. Epub 20230424. doi: 10.1186/s12864-023-09310-8. PubMed PMID: 37095444; PMCID: PMC10123997.
  9. Drzewiecka M, Gajos-Michniewicz A, Hoser G, Jaśniak D, Barszczewska-Pietraszek G, Sitarek P, Czarny P, Piekarski J, Radek M, Czyż M, Skorski T, Śliwiński T. Histone Deacetylases (HDAC) Inhibitor-Valproic Acid Sensitizes Human Melanoma Cells to Dacarbazine and PARP Inhibitor. Genes (Basel). 2023;14(6). Epub 20230620. doi: 10.3390/genes14061295. PubMed PMID: 37372475; PMCID: PMC10298302.
  10. Drzewiecka M, Jaśniak D, Barszczewska-Pietraszek G, Czarny P, Kobrzycka A, Wieczorek M, Radek M, Szemraj J, Skorski T, Śliwiński T. Class I HDAC Inhibition Leads to a Downregulation of FANCD2 and RAD51, and the Eradication of Glioblastoma Cells. J Pers Med. 2023;13(9). Epub 20230827. doi: 10.3390/jpm13091315. PubMed PMID: 37763083; PMCID: PMC10532614.
  11. Fried W, Tyagi M, Minakhin L, Chandramouly G, Tredinnick T, Ramanjulu M, Auerbacher W, Calbert M, Rusanov T, Hoang T, Borisonnik N, Betsch R, Krais JJ, Wang Y, Vekariya UM, Gordon J, Morton G, Kent T, Skorski T, Johnson N, Childers W, Chen XS, Pomerantz RT. Discovery of a small-molecule inhibitor that traps Polθ on DNA and synergizes with PARP inhibitors. Nat Commun. 2024;15(1):2862. Epub 20240405. doi: 10.1038/s41467-024-46593-1. PubMed PMID: 38580648; PMCID: PMC10997755.
  12. Friedman-DeLuca M, Patel PP, Karadal-Ferrena B, Barth ND, Duran CL, Ye X, Papanicolaou M, Condeelis JS, Oktay MH, Borriello L, Entenberg D. Tracking Tumor Cell Dissemination from Lung Metastases Using Photoconversion. J Vis Exp. 2023(197). Epub 20230707. doi: 10.3791/65732. PubMed PMID: 37486129; PMCID: PMC10832329.
  13. Fuller AD, Karami AL, Kabir MF, Klochkova A, Jackson JL, Mu A, Tan Y, Klein-Szanto AJ, Whelan KA. Eosinophilic esophagitis-associated epithelial remodeling may limit esophageal carcinogenesis. Front Allergy. 2023;4:1086032. Epub 20230329. doi: 10.3389/falgy.2023.1086032. PubMed PMID: 37064719; PMCID: PMC10090679.
  14.  Fuller AD, Whelan KA. The Underappreciated Role of Eosinophils in Esophageal Cancer. Cell Mol Gastroenterol Hepatol. 2023;16(6):1036-7. Epub 20231012. doi: 10.1016/j.jcmgh.2023.09.011. PubMed PMID: 37839465; PMCID: PMC10685143.
  15. Golovine K, Abalakov G, Lian Z, Chatla S, Karami A, Chitrala KN, Madzo J, Nieborowska-Skorska M, Huang J, Skorski T. ABL1 kinase as a tumor suppressor in AML1-ETO and NUP98-PMX1 leukemias. Blood Cancer J. 2023;13(1):42. Epub 20230323. doi: 10.1038/s41408-023-00810-0. PubMed PMID: 36959186; PMCID: PMC10036529.
  16. Gray ZH, Chakraborty D, Duttweiler RR, Alekbaeva GD, Murphy SE, Chetal K, Ji F, Ferman BI, Honer MA, Wang Z, Myers C, Sun R, Kaniskan H, Toma MM, Bondarenko EA, Santoro JN, Miranda C, Dillingham ME, Tang R, Gozani O, Jin J, Skorski T, Duy C, Lee H, Sadreyev RI, Whetstine JR. Epigenetic balance ensures mechanistic control of MLL amplification and rearrangement. Cell. 2023;186(21):4528-45.e18. Epub 20231002. doi: 10.1016/j.cell.2023.09.009. PubMed PMID: 37788669; PMCID: PMC10591855.
  17. Guo Q, Xin M, Lu Q, Feng D, Yang V, Peng LF, Whelan KA, Hu W, Wu S, Yang X, Wang H, Rothberg BS, Gamero AM, Gerhard GS, Gao B, Yang L. A novel NEDD4L-TXNIP-CHOP axis in the pathogenesis of nonalcoholic steatohepatitis. Theranostics. 2023;13(7):2210-25. Epub 20230409. doi: 10.7150/thno.81192. PubMed PMID: 37153733; PMCID: PMC10157740.
  18. Ito F, Li Z, Minakhin L, Chandramouly G, Tyagi M, Betsch R, Krais JJ, Taberi B, Vekariya U, Calbert M, Skorski T, Johnson N, Chen XS, Pomerantz RT. Structural basis for a Polθ helicase small-molecule inhibitor revealed by cryo-EM. Nat Commun. 2024;15(1):7003. Epub 20240814. doi: 10.1038/s41467-024-51351-4. PubMed PMID: 39143110; PMCID: PMC11324745.
  19. Kabir MF, Jackson JL, Fuller AD, Gathuka L, Karami AL, Conde DG, Klochkova A, Mu A, Cai KQ, Klein-Szanto AJ, Muir AB, Whelan KA. Diclofenac exhibits cytotoxic activity associated with metabolic alterations and p53 induction in ESCC cell lines and decreases ESCC tumor burden in vivo. Carcinogenesis. 2023;44(2):182-95. doi: 10.1093/carcin/bgad019. PubMed PMID: 37014121; PMCID: PMC10215983.
  20. Karami A, Skorski T. DNA damage response genes as biomarkers of therapeutic outcomes in acute myeloid leukemia patients. Leukemia. 2024;38(6):1407-10. Epub 20240511. doi: 10.1038/s41375-024-02269-9. PubMed PMID: 38734788; PMCID: PMC11147752.
  21. Karpińska K, Mehlich D, Sabbasani VR, Łomiak M, Torres-Ayuso P, Wróbel K, Truong VN, Serwa R, Swenson RE, Brognard J, Marusiak AA. Selective Degradation of MLK3 by a Novel CEP1347-VHL-02 PROTAC Compound Limits the Oncogenic Potential of TNBC. J Med Chem. 2024;67(17):15012-28. Epub 20240829. doi: 10.1021/acs.jmedchem.4c00577. PubMed PMID: 39207123; PMCID: PMC11403673.
  22. Klochkova A, Karami AL, Fuller AD, Parham LR, Panchani SR, Natarajan S, Jackson JL, Mu A, Tan Y, Cai KQ, Klein-Szanto AJ, Muir AB, Tétreault MP, Graña X, Hamilton KE, Whelan KA. Autophagy Contributes to Homeostasis in Esophageal Epithelium Where High Autophagic Vesicle Level Marks Basal Cells With Limited Proliferation and Enhanced Self-Renewal Potential. Cell Mol Gastroenterol Hepatol. 2024;18(1):15-40. Epub 20240305. doi: 10.1016/j.jcmgh.2024.02.018. PubMed PMID: 38452871; PMCID: PMC11126828.
  23. Kumari S, Gupta S, Jamil A, Tabatabaei D, Karakashev S. Exploring Metabolic Approaches for Epithelial Ovarian Cancer Therapy. J Cell Physiol. 2024:e31495. Epub 20241215. doi: 10.1002/jcp.31495. PubMed PMID: 39676338.
  24. Lilly AC, Astsaturov I, Golemis EA. Intrapancreatic fat, pancreatitis, and pancreatic cancer. Cell Mol Life Sci. 2023;80(8):206. Epub 20230715. doi: 10.1007/s00018-023-04855-z. PubMed PMID: 37452870; PMCID: PMC10349727.
  25. Liu ZS, Sinha S, Bannister M, Song A, Arriaga-Gomez E, McKeeken AJ, Bonner EA, Hanson BK, Sarchi M, Takashima K, Zong D, Corral VM, Nguyen E, Yoo J, Chiraphapphaiboon W, Leibson C, McMahon MC, Rai S, Swisher EM, Sachs Z, Chatla S, Stirewalt DL, Deeg HJ, Skorski T, Papapetrou EP, Walter MJ, Graubert TA, Doulatov S, Lee SC, Nguyen HD. R-Loop Accumulation in Spliceosome Mutant Leukemias Confers Sensitivity to PARP1 Inhibition by Triggering Transcription-Replication Conflicts. Cancer Res. 2024;84(4):577-97. doi: 10.1158/0008-5472.Can-23-3239. PubMed PMID: 37967363; PMCID: PMC10922727.
  26. Muir AB, Karakasheva TA, Whelan KA. Epithelial-Fibroblast Crosstalk in Eosinophilic Esophagitis. Cell Mol Gastroenterol Hepatol. 2024;17(5):713-8. Epub 20240203. doi: 10.1016/j.jcmgh.2024.01.020. PubMed PMID: 38316214; PMCID: PMC10957450.
  27. Nguyen T, Carrieri FA, Connis N, Lafargue A, Chang J, Chan A, Shetty AC, Song Y, Hoang T, Jagtap S, Chowdhury DD, Khan MA, Gabrielson KL, Rezaee M, Torres-Ayuso P, Brognard J, Hann CL, Tran PT. TNIK Inhibition Sensitizes TNIK-Overexpressing Lung Squamous Cell Carcinoma to Radiotherapy. Mol Cancer Ther. 2024:Of1-of11. Epub 20240610. doi: 10.1158/1535-7163.Mct-23-0412. PubMed PMID: 38853421.
  28. Nicolas E, Kosmider B, Cukierman E, Borghaei H, Golemis EA, Borriello L. Cancer treatments as paradoxical catalysts of tumor awakening in the lung. Cancer Metastasis Rev. 2024;43(4):1165-83. Epub 20240704. doi: 10.1007/s10555-024-10196-5. PubMed PMID: 38963567; PMCID: PMC11554904.
  29. Nikonova AS, Deneka AY, Silva FN, Pirestani S, Tricarico R, Kiseleva AA, Zhou Y, Nicolas E, Flieder DB, Grivennikov SI, Golemis EA. Loss of Pkd1 limits susceptibility to colitis and colorectal cancer. Oncogenesis. 2023;12(1):40. Epub 20230805. doi: 10.1038/s41389-023-00486-y. PubMed PMID: 37542051; PMCID: PMC10403611.
  30. Parham LR, Williams PA, Katada K, Nettleford SK, Chatterji P, Acheampong KK, Danan CH, Ma X, Simon LA, Naughton KE, Mizuno R, Karakasheva T, McMillan EA, Whelan KA, Brady DC, Shaffer SM, Hamilton KE. IGF2BP1/IMP1 Deletion Enhances a Facultative Stem Cell State via Regulation of MAP1LC3B. Cell Mol Gastroenterol Hepatol. 2024;17(3):439-51. Epub 20231209. doi: 10.1016/j.jcmgh.2023.12.001. PubMed PMID: 38081361; PMCID: PMC10835461.
  31. Park PH, Keith K, Calendo G, Jelinek J, Madzo J, Gharaibeh RZ, Ghosh J, Sapienza C, Jobin C, Issa JJ. Association between gut microbiota and CpG island methylator phenotype in colorectal cancer. Gut Microbes. 2024;16(1):2363012. Epub 20240611. doi: 10.1080/19490976.2024.2363012. PubMed PMID: 38860458; PMCID: PMC11174071.
  32. Ren F, Aliper A, Chen J, Zhao H, Rao S, Kuppe C, Ozerov IV, Zhang M, Witte K, Kruse C, Aladinskiy V, Ivanenkov Y, Polykovskiy D, Fu Y, Babin E, Qiao J, Liang X, Mou Z, Wang H, Pun FW, Torres-Ayuso P, Veviorskiy A, Song D, Liu S, Zhang B, Naumov V, Ding X, Kukharenko A, Izumchenko E, Zhavoronkov A. A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models. Nat Biotechnol. 2024. Epub 20240308. doi: 10.1038/s41587-024-02143-0. PubMed PMID: 38459338.
  33. Sasaki M, Hara T, Wang JX, Zhou Y, Kennedy KV, Umeweni CN, Alston MA, Spergel ZC, Ishikawa S, Teranishi R, Nakagawa R, McMillan EA, Whelan KA, Karakasheva TA, Hamilton KE, Ruffner MA, Muir AB. Lysyl Oxidase Regulates Epithelial Differentiation and Barrier Integrity in Eosinophilic Esophagitis. Cell Mol Gastroenterol Hepatol. 2024;17(6):923-37. Epub 20240209. doi: 10.1016/j.jcmgh.2024.01.025. PubMed PMID: 38340809; PMCID: PMC11026689.
  34. Serebriiskii IG, Pavlov VA, Andrianov GV, Litwin S, Basickes S, Newberg JY, Frampton GM, Meyer JE, Golemis EA. Source, co-occurrence, and prognostic value of PTEN mutations or loss in colorectal cancer. NPJ Genom Med. 2023;8(1):40. Epub 20231124. doi: 10.1038/s41525-023-00384-7. PubMed PMID: 38001126; PMCID: PMC10674024.
  35. Shrestha J, Santerre M, Allen CN, Arjona SP, Hooper R, Mukerjee R, Kaul M, Shcherbik N, Soboloff J, Sawaya BE. HIV-1 gp120 protein promotes HAND through the calcineurin pathway activation. Mitochondrion. 2023;70:31-40. Epub 20230315. doi: 10.1016/j.mito.2023.03.003. PubMed PMID: 36925028; PMCID: PMC10484070.
  36. Sullivan-Reed K, Toma MM, Drzewiecka M, Nieborowska-Skorska M, Nejati R, Karami A, Wasik MA, Sliwinski T, Skorski T. Simultaneous Targeting of DNA Polymerase Theta and PARP1 or RAD52 Triggers Dual Synthetic Lethality in Homologous Recombination-Deficient Leukemia Cells. Mol Cancer Res. 2023;21(10):1017-22. doi: 10.1158/1541-7786.Mcr-22-1035. PubMed PMID: 37358557; PMCID: PMC10654933.
  37. Thej C, Roy R, Cheng Z, Garikipati VNS, Truongcao MM, Joladarashi D, Mallaredy V, Cimini M, Gonzalez C, Magadum A, Ghosh J, Benedict C, Koch WJ, Kishore R. Epigenetic mechanisms regulate sex differences in cardiac reparative functions of bone marrow progenitor cells. NPJ Regen Med. 2024;9(1):17. Epub 20240429. doi: 10.1038/s41536-024-00362-2. PubMed PMID: 38684697; PMCID: PMC11058271.
  38. Toma MM, Karami A, Nieborowska-Skorska M, Chirtala KN, Pepek M, Hadzijusufovic E, Stoklosa T, Valent P, Skorski T. Clonal medicine targeting DNA damage response eradicates leukemia. Leukemia. 2024;38(3):671-5. Epub 20240116. doi: 10.1038/s41375-024-02138-5. PubMed PMID: 38228681; PMCID: PMC10912018.
  39. Toma MM, Skorski T. Star wars against leukemia: attacking the clones. Leukemia. 2024;38(11):2293-302. Epub 20240902. doi: 10.1038/s41375-024-02369-6. PubMed PMID: 39223295; PMCID: PMC11519008.
  40. Torres-Ayuso P, Katerji M, Mehlich D, Lookingbill SA, Sabbasani VR, Liou H, Casillas AL, Chauhan SS, Serwa R, Rubin MR, Marusiak AA, Swenson RE, Warfel NA, Brognard J. PIM1 targeted degradation prevents the emergence of chemoresistance in prostate cancer. Cell Chem Biol. 2024;31(2):326-37.e11. Epub 20231127. doi: 10.1016/j.chembiol.2023.10.023. PubMed PMID: 38016478; PMCID: PMC10922308.
  41. Vekariya U, Minakhin L, Chandramouly G, Tyagi M, Kent T, Sullivan-Reed K, Atkins J, Ralph D, Nieborowska-Skorska M, Kukuyan AM, Tang HY, Pomerantz RT, Skorski T. PARG is essential for Polθ-mediated DNA end-joining by removing repressive poly-ADP-ribose marks. Nat Commun. 2024;15(1):5822. Epub 20240711. doi: 10.1038/s41467-024-50158-7. PubMed PMID: 38987289; PMCID: PMC11236980.
  42. Vekariya U, Toma M, Nieborowska-Skorska M, Le BV, Caron MC, Kukuyan AM, Sullivan-Reed K, Podszywalow-Bartnicka P, Chitrala KN, Atkins J, Drzewiecka M, Feng W, Chan J, Chatla S, Golovine K, Jelinek J, Sliwinski T, Ghosh J, Matlawska-Wasowska K, Chandramouly G, Nejati R, Wasik M, Sykes SM, Piwocka K, Hadzijusufovic E, Valent P, Pomerantz RT, Morton G, Childers W, Zhao H, Paietta EM, Levine RL, Tallman MS, Fernandez HF, Litzow MR, Gupta GP, Masson JY, Skorski T. DNA polymerase θ protects leukemia cells from metabolically induced DNA damage. Blood. 2023;141(19):2372-89. doi: 10.1182/blood.2022018428. PubMed PMID: 36580665; PMCID: PMC10273171.
  43. Wasserman JS, Faezov B, Patel KR, Kurimchak AM, Palacio SM, Glass DJ, Fowle H, McEwan BC, Xu Q, Zhao Z, Cressey L, Johnson N, Duncan JS, Kettenbach AN, Dunbrack RL, Jr., Graña X. FAM122A ensures cell cycle interphase progression and checkpoint control by inhibiting B55α/PP2A through helical motifs. Nat Commun. 2024;15(1):5776. Epub 20240710. doi: 10.1038/s41467-024-50015-7. PubMed PMID: 38982062; PMCID: PMC11233601.
  44. Wasserman JS, Feiser F, Palacio S, Patel K, Gonzalez J, Fowle H, Graña X. Protocol to assess substrate dephosphorylation by serine/threonine phosphoprotein phosphatases in vitro. STAR Protoc. 2023;4(2):102148. Epub 20230418. doi: 10.1016/j.xpro.2023.102148. PubMed PMID: 37074907; PMCID: PMC10322857.
  45. Wasserman JS, Fowle H, Hashmi R, Atar D, Patel KR, Yarmahmoodi A, Macfarlane AW, Tan Y, Cukierman E, Gligorijevic B, Karami A, Whelan KA, Campbell KS, Graña X. Derivation of human primary prostate epithelial cell lines by differentially targeting the CDKN2A locus along with expression of hTERT. Sci Rep. 2024;14(1):20409. Epub 20240902. doi: 10.1038/s41598-024-71306-5. PubMed PMID: 39223207; PMCID: PMC11369182.
  46. Williams PA, Naughton KE, Simon LA, Soto GE, Parham LR, Ma X, Danan CH, Hu W, Friedman ES, McMillan EA, Mehta H, Stoltz MA, Ocaña JS, Zackular JP, Bittinger K, Whelan KA, Karakasheva TA, Hamilton KE. Intestinal epithelial autophagy is required for the regenerative benefit of calorie restriction. Am J Physiol Gastrointest Liver Physiol. 2023;324(5):G354-g68. Epub 20230228. doi: 10.1152/ajpgi.00248.2022. PubMed PMID: 36852920; PMCID: PMC10069975.
  47. Wolczyk M, Serwa R, Kominek A, Klejman A, Milek J, Chwałek M, Turos-Korgul L, Charzyńska A, Dabrowski M, Dziembowska M, Skorski T, Piwocka K, Podszywalow-Bartnicka P. TIAR and FMRP shape pro-survival nascent proteome of leukemia cells in the bone marrow microenvironment. iScience. 2023;26(4):106543. Epub 20230331. doi: 10.1016/j.isci.2023.106543. PubMed PMID: 37123244; PMCID: PMC10140000.
  48. Zhou B, Basu J, Kazmi HR, Chitrala KN, Mo X, Preston-Alp S, Cai KQ, Kappes D, Zaidi MR. Interferon-gamma signaling promotes melanoma progression and metastasis. Oncogene. 2023;42(5):351-63. Epub 20221203. doi: 10.1038/s41388-022-02561-x. PubMed PMID: 36463370; PMCID: PMC9991867.

2023-2024  - FCCC Adjunct Faculty Publications

(only publications as first or last author are listed)  

  1. Benton D, Yee Chow H, Karchugina S, Chernoff J. Synergistic effect of PAK and Hippo pathway inhibitor combination in NF2-deficient Schwannoma. PLoS One. 2024;19(7):e0305121. Epub 20240731. doi: 10.1371/journal.pone.0305121. PubMed PMID: 39083549; PMCID: PMC11290668.
  2. Budagyan K, Cannon AC, Chernoff J. A Facile Method to Append a Bio-ID Tag to Endogenous Mutant Kras Alleles. Methods Mol Biol. 2024;2797:351-62. doi: 10.1007/978-1-0716-3822-4_25. PubMed PMID: 38570472.
  3. Chang WL, Ghosh J, Cooper HS, Vanderveer L, Schultz B, Zhou Y, Harvey KN, Kaunga E, Devarajan K, Li Y, Jelinek J, Fragoso MF, Sapienza C, Clapper ML. Folic Acid Supplementation Promotes Hypomethylation in Both the Inflamed Colonic Mucosa and Colitis-Associated Dysplasia. Cancers (Basel). 2023;15(11). Epub 20230527. doi: 10.3390/cancers15112949. PubMed PMID: 37296911; PMCID: PMC10252136.
  4. Chhabra Y, Bielefeldt-Ohmann H, Brooks TL, Brooks AJ, Waters MJ. Roles of Growth Hormone-Dependent JAK-STAT5 and Lyn Kinase Signaling in Determining Lifespan and Cancer Incidence. Endocrinology. 2024;165(11). doi: 10.1210/endocr/bqae136. PubMed PMID: 39378329; PMCID: PMC11500606.
  5. Chhabra Y, Fane ME, Pramod S, Hüser L, Zabransky DJ, Wang V, Dixit A, Zhao R, Kumah E, Brezka ML, Truskowski K, Nandi A, Marino-Bravante GE, Carey AE, Gour N, Maranto DA, Rocha MR, Harper EI, Ruiz J, Lipson EJ, Jaffee EM, Bibee K, Sunshine JC, Ji H, Weeraratna AT. Sex-dependent effects in the aged melanoma tumor microenvironment influence invasion and resistance to targeted therapy. Cell. 2024;187(21):6016-34.e25. Epub 20240906. doi: 10.1016/j.cell.2024.08.013. PubMed PMID: 39243764; PMCID: PMC11580838.
  6. Fazliyeva R, Makhov P, Uzzo RG, Kolenko VM. Targeting NPC1 in Renal Cell Carcinoma. Cancers (Basel). 2024;16(3). Epub 20240125. doi: 10.3390/cancers16030517. PubMed PMID: 38339268; PMCID: PMC10854724.
  7. Fu J, Fu C, Wang RS, Geynisman DM, Ghatalia P, Lynch SM, Harrison SR, Tagai EK, Ragin C. Current Status and Future Direction to Address Disparities in Diversity, Equity, and Inclusion in Prostate Cancer Care. Curr Oncol Rep. 2023;25(7):699-708. Epub 20230403. doi: 10.1007/s11912-023-01399-0. PubMed PMID: 37010786; PMCID: PMC10068208.
  8. Gao T, Cho EA, Zhang P, Wu J. Inhibition of talin-induced integrin activation by a double-hit stapled peptide. Structure. 2023;31(8):948-57.e3. Epub 20230626. doi: 10.1016/j.str.2023.05.016. PubMed PMID: 37369205; PMCID: PMC10526925.
  9. Gupta S, Lee HO, Wang L, Kruger WD. Examination of two different proteasome inhibitors in reactivating mutant human cystathionine β-synthase in mice. PLoS One. 2023;18(6):e0286550. Epub 20230615. doi: 10.1371/journal.pone.0286550. PubMed PMID: 37319242; PMCID: PMC10270616.
  10. Hall MJ, D'Avanzo PA, Chertock Y, Kelly PJA, Brajuha J, Singley K, Luck CC, Bass SB. Oncologists' perceptions of tumor genomic profiling and barriers to communicating secondary hereditary risks to African American cancer patients. BMC Cancer. 2024;24(1):412. Epub 20240402. doi: 10.1186/s12885-024-12184-y. PubMed PMID: 38566032; PMCID: PMC10988900.
  11. Hassan D, Menges CW, Testa JR, Bellacosa A. AKT kinases as therapeutic targets. J Exp Clin Cancer Res. 2024;43(1):313. Epub 20241129. doi: 10.1186/s13046-024-03207-4. PubMed PMID: 39614261; PMCID: PMC11606119.
  12. Hussen AS, Kravitz HL, Freudenthal BD, Whitaker AM. Oxidative DNA damage on the VEGF G-quadruplex forming promoter is repaired via long-patch BER. Environ Mol Mutagen. 2024;65 Suppl 1(Suppl 1):25-39. Epub 20230901. doi: 10.1002/em.22570. PubMed PMID: 37606505; PMCID: PMC10984112.
  13. Ioffe D, McSweeny M, Hall MJ. Precision Medicine in the Era of Genetic Testing: Microsatellite Instability Evolved. Clin Colon Rectal Surg. 2024;37(3):157-71. Epub 20230725. doi: 10.1055/s-0043-1770385. PubMed PMID: 38617845; PMCID: PMC11007599.
  14. Kadariya Y, Sementino E, Ruan M, Cheung M, Hadikhani P, Osmanbeyoglu HU, Klein-Szanto AJ, Cai K, Testa JR. Low Exposures to Amphibole or Serpentine Asbestos in Germline Bap1-mutant Mice Induce Mesothelioma Characterized by an Immunosuppressive Tumor Microenvironment. Cancer Res Commun. 2024;4(4):1004-15. doi: 10.1158/2767-9764.Crc-23-0423. PubMed PMID: 38592450; PMCID: PMC11000687.
  15. Lee EH, Zinshteyn D, Miglo F, Wang MQ, Reinach J, Chau CM, Grosstephan JM, Correa I, Costa K, Vargas A, Johnson A, Longo SM, Alexander JI, O'Reilly AM. Sequential events during the quiescence to proliferation transition establish patterns of follicle cell differentiation in the Drosophila ovary. Biol Open. 2023;12(1). Epub 20230112. doi: 10.1242/bio.059625. PubMed PMID: 36524613; PMCID: PMC9867896.
  16.  Lee HO, Gupta K, Wang L, Dunbrack RL, Majtan T, Kruger WD. Impact of primary sequence changes on the self-association properties of mammalian cystathionine beta-synthase enzymes. Protein Sci. 2024;33(12):e5223. doi: 10.1002/pro.5223. PubMed PMID: 39548832; PMCID: PMC11568414.
  17. Liu JC, Egleston BL, Blackman E, Ragin C. Racial survival disparities in head and neck cancer clinical trials. J Natl Cancer Inst. 2023;115(3):288-94. doi: 10.1093/jnci/djac219. PubMed PMID: 36477855; PMCID: PMC9996207.
  18. Luck CC, Bass SB, Chertock Y, Kelly PJA, Singley K, Hoadley A, Hall MJ. Understanding perceptions of tumor genomic profile testing in Black/African American cancer patients in a qualitative study: the role of medical mistrust, provider communication, and family support. J Community Genet. 2024;15(3):281-92. Epub 20240216. doi: 10.1007/s12687-024-00700-3. PubMed PMID: 38366313; PMCID: PMC11217212.
  19. Majtan T, Kožich V, Kruger WD. Recent therapeutic approaches to cystathionine beta-synthase-deficient homocystinuria. Br J Pharmacol. 2023;180(3):264-78. Epub 20221208. doi: 10.1111/bph.15991. PubMed PMID: 36417581; PMCID: PMC9822868.
  20. Makhov P, Fazliyeva R, Tufano A, Uzzo RG, Kolenko VM. Examining the Effect of PARP-1 Inhibitors on Transcriptional Activity of Androgen Receptor in Prostate Cancer Cells. Methods Mol Biol. 2023;2609:329-35. doi: 10.1007/978-1-0716-2891-1_19. PubMed PMID: 36515844; PMCID: PMC10103651.
  21. Maskalenko NA, Zahroun S, Tsygankova O, Anikeeva N, Sykulev Y, Campbell KS. The FcγRIIIA (CD16) L48-H/R polymorphism enhances NK cell-mediated antibody-dependent cellular cytotoxicity by promoting serial killing. Cancer Immunol Res. 2024. Epub 20241212. doi: 10.1158/2326-6066.Cir-24-0384. PubMed PMID: 39666369.
  22. Menges CW, Hassan D, Cheung M, Bellacosa A, Testa JR. Alterations of the AKT Pathway in Sporadic Human Tumors, Inherited Susceptibility to Cancer, and Overgrowth Syndromes. Curr Top Microbiol Immunol. 2024. Epub 20240828. doi: 10.1007/82_2024_278. PubMed PMID: 39192048.
  23. Nejati R, Neumann-Domer R, Liu Z, Koslosky L, Neumann-Domer E, Pei J, Wang YL, Testa JR. Isochromosome 7p, i(7)(p10): A rare AML, myelodysplasia-related entity. Leuk Res Rep. 2023;20:100387. Epub 20230829. doi: 10.1016/j.lrr.2023.100387. PubMed PMID: 37701905; PMCID: PMC10493252.
  24. Ruiz-Whalen DM, Aichele CP, Dyson ER, Gallen KC, Stark JV, Saunders JA, Simonet JC, Ventresca EM, Fuentes IM, Marmol N, Moise E, Neubert BC, Riggs DJ, Self AM, Alexander JI, Boamah E, Browne AJ, Correa I, Foster MJ, Harrington N, Holiday TJ, Henry RA, Lee EH, Longo SM, Lorenz LD, Martinez E, Nikonova A, Radu M, Smith SC, Steele LA, Strochlic TI, Archer NF, Aykit YJ, Bolotsky AJ, Boyle M, Criollo J, Eldor O, Cruz G, Fortuona VN, Gounder SD, Greenwood N, Ji KW, Johnson A, Lara S, Montanez B, Saurman M, Singh T, Smith DR, Stapf CA, Tondapu T, Tsiobikas C, Habas R, O'Reilly AM. Gaining Wings to FLY: Using Drosophila Oogenesis as an Entry Point for Citizen Scientists in Laboratory Research. Methods Mol Biol. 2023;2626:399-444. doi: 10.1007/978-1-0716-2970-3_22. PubMed PMID: 36715918.
  25. Sahin Y, Pei J, Baldwin DA, Mansoor N, Koslosky L, Abdelmessieh P, Wang YL, Nejati R, Testa JR. Acute myeloid leukemia with a novel AKAP9::PDGFRA fusion transformed from essential thrombocythemia: A case report and mini review. Leuk Res Rep. 2024;21:100465. Epub 20240531. doi: 10.1016/j.lrr.2024.100465. PubMed PMID: 38952949; PMCID: PMC11215950.
  26. Sementino E, Hassan D, Bellacosa A, Testa JR. AKT and the Hallmarks of Cancer. Cancer Res. 2024;84(24):4126-39. doi: 10.1158/0008-5472.Can-24-1846. PubMed PMID: 39437156.
  27. Singhal S, Riggs ED, Ruth KJ, Chavez-Salas JP, Chertock Y, Daly MB, Hall MJ. Uptake of Aspirin Chemoprevention in Patients With Lynch Syndrome. JCO Precis Oncol. 2024;8:e2400562. Epub 20241115. doi: 10.1200/po-24-00562. PubMed PMID: 39546469; PMCID: PMC11573245.
  28. Testa JR, Kadariya Y, Friedberg JS. Targeting inflammatory factors for chemoprevention and cancer interception to tackle malignant mesothelioma. Oncoscience. 2024;11:53-7. Epub 20240523. doi: 10.18632/oncoscience.605. PubMed PMID: 38784478; PMCID: PMC11115283.
  29. Tetzlaff ED, Hylton HM, Ruth KJ, Hasse Z, Hall MJ. Moral Distress, Organizational Climate, and the Risk of Burnout Among Physician Assistants in Oncology. JCO Oncol Pract. 2023;19(5):e639-e49. Epub 20230213. doi: 10.1200/op.22.00641. PubMed PMID: 36780593; PMCID: PMC10414748.
  30. Tricarico R, Madzo J, Scher G, Cohen M, Jelinek J, Maegawa S, Nagarathinam R, Scher C, Chang WC, Nicolas E, Slifker M, Zhou Y, Devarajan K, Cai KQ, Kwok T, Nakajima P, Xu J, Mancuso P, Doneddu V, Bagella L, Williams R, Balachandran S, Maskalenko N, Campbell K, Ma X, Cañadas I, Viana-Errasti J, Moreno V, Valle L, Grivennikov S, Peshkova I, Kurilenko N, Mazitova A, Koltsova E, Lee H, Walsh M, Duttweiler R, Whetstine JR, Yen TJ, Issa JP, Bellacosa A. TET1 and TDG Suppress Inflammatory Response in Intestinal Tumorigenesis: Implications for Colorectal Tumors With the CpG Island Methylator Phenotype. Gastroenterology. 2023;164(6):921-36.e1. Epub 20230208. doi: 10.1053/j.gastro.2023.01.039. PubMed PMID: 36764492; PMCID: PMC10586516.
  31. Xu Q, Dunbrack RL. The protein common assembly database (ProtCAD)-a comprehensive structural resource of protein complexes. Nucleic Acids Res. 2023;51(D1):D466-d78. doi: 10.1093/nar/gkac937. PubMed PMID: 36300618; PMCID: PMC9825537.
  32. Yang Y, Valdés-Rives SA, Liu Q, Gao T, Burudpakdee C, Li Y, Tan J, Tan Y, Koch CA, Rong Y, Houser SR, Wei S, Cai KQ, Wu J, Cheng SY, Wechsler-Reya R, Yang ZJ. Thyroid hormone suppresses medulloblastoma progression through promoting terminal differentiation of tumor cells. Cancer Cell. 2024;42(8):1434-49.e5. doi: 10.1016/j.ccell.2024.07.008. PubMed PMID: 39137728; PMCID: PMC11565524.
  33. Zeigler-Johnson C, McDonald AC, Pinheiro P, Lynch S, Taioli E, Joshi S, Alpert N, Baudin J, Joachim C, Deloumeaux J, Oliver J, Bhakkan-Mambir B, Beaubrun-Renard M, Ortiz AG, Ragin C. Trends in prostate cancer incidence among Black men in the Caribbean and the United States. Prostate. 2023;83(12):1207-16. Epub 20230527. doi: 10.1002/pros.24580. PubMed PMID: 37244749; PMCID: PMC11256998.
  34. Zhang J, Yang Y, Li X, Li G, Mizukami T, Liu Y, Wang Y, Xu G, Roder H, Zhang L, Yang ZJ. PDLIM3 supports hedgehog signaling in medulloblastoma by facilitating cilia formation. Cell Death Differ. 2023;30(5):1198-210. Epub 20230222. doi: 10.1038/s41418-023-01131-2. PubMed PMID: 36813922; PMCID: PMC10154305.